PET Imaging-Based Evaluaion of Hepaobiliary transport in Humans with [18F]PTV

PET Imaging-Based Evaluaion of Hepaobiliary transport in Humans with [18F]PTV - PET study in Humans with [18F]PTV

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000030049

Enrollment

Registered

2017-11-20

Start date

2017-11-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

This study includes PET scan for 2 times. For the first visit, the participants take only water. For the second visit, they take livalo with water.

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: healhy male who can have PET scan for about 90 min and temporal blood sampling for about 15 points.

Exclusion criteria

Exclusion criteria: 1.those who have compligating disordes of severe cenral nervous system, liver, and kidney damage. 2.those who take hyperlipidemia treatment, tuberculosis drug and other treatments for target regions. 3.those who are claustrophobia. 4.those who are not suiable for this study assessed by medical docors judge

Design outcomes

Primary

Measure	Time frame
Disribution of Radioacivity in human dbdominal region and blood after adminisration of [18F]PTV	—

Secondary

Measure	Time frame
metabolite analysis of human blood by TLC	—

Countries

Japan

Contacts

Public ContactEmi Yamano

RIKEN Center for Biosystems Dynamics Research Pathophysiological and Health Science Team

emi.yamano@riken.jp078-304-7124

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026